Cansativa

Cansativa is Germany's leading medical cannabis wholesaler and B2B platform. Founded in 2017, the company connects producers, pharmacies, doctors and patients through a distribution and warehousing ecosystem built for the medical cannabis supply chain. Its operations extend across Germany and the wider European market.

The firm operates the Cansativa B2B Cannabis Platform, described as the largest B2B platform for cannabis in Europe, providing independent market access alongside warehousing and distribution capacity. Technical work spans supply chain and platform development, GMP/GDP-certified pharmaceutical handling, logistics, and medical cannabis import and manufacturing. The company holds manufacturing, import and wholesale licenses and is GMP and GDP certified.

Its stated standards centre on quality, reliability and patient care, with a mission-driven focus on access to medicine. Cansativa describes its role as enabling the industry it operates in, with an entrepreneurial, pioneering and market-building orientation.